Evidence map›Paper›PMID 39008228›Full record

ArticleCerebellum (London, England)2024

COVID-19-Associated Cerebellitis: A Case Report and Rehabilitation Outcome.

Roberto Tedeschi, Vincenza Amoruso, Valentina Boetto, Davide Glorioso, Lucia D'Auria, Danilo Donati

Abstract readCase Reports
In one paragraph

Article in Cerebellum (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Roberto TedeschiDepartment of Biomedical and Neuromotor Sciences (DIBINEM), Alma Mater Studiorum, University of Bologna, Via Zamboni 33, Bologna, 40126, Italy. roberto.tedeschi2@unibo.it.
Vincenza AmorusoDepartment of Geriatrics and Orthopaedics, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.
Valentina BoettoDepartment of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, 27100, Italy.
Davide GloriosoNeuro-Orthopedic Unit, Sol et Salus Hospital, Rimini, 47922, Italy.
Lucia D'AuriaPhysical Therapy and Rehabilitation Unit, Policlinico di Modena, Modena, 41125, Italy.
Danilo DonatiPhysical Therapy and Rehabilitation Unit, Policlinico di Modena, Modena, 41125, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe COVID-19 pandemic has brought attention to neurological complications, including cerebellitis, characterized by inflammation of the cerebellum. Despite its rare occurrence, cerebellitis has been associated with COVID-19 infection, albeit the pathogenic mechanisms remain unclear. CASE REPORT: We present the case of a 22-year-old male with acute onset ataxia and dysarthria during a SARS-CoV-2 infection. Diagnostic evaluations ruled out other causes, confirming cerebellitis. Treatment included steroid therapy, vitamin supplementation, physiotherapy, and intravenous immunoglobulins. Rehabilitation focused on enhancing balance, coordination, and daily activities. The patient showed significant improvement in functional abilities, with increased autonomy in daily activities and improved ambulation. Despite persistent mild symptoms, the multidisciplinary rehabilitation approach led to remarkable progress.

conclusionsThis case underscores the importance of recognizing and managing neurological complications, such as cerebellitis, in COVID-19 patients. A comprehensive approach combining medical treatment and rehabilitation is essential for optimizing outcomes. Further research is needed to elucidate the pathogenesis and optimal management strategies for such complications.

Indexed as

Cerebellar DiseasesCOVID-19CerebellumHumansImmunoglobulins, IntravenousMalePhysical Therapy ModalitiesSARS-CoV-2Treatment OutcomeYoung AdultImmunoglobulins, IntravenousCerebellitisCOVID-19Multidisciplinary approachNeurological complicationsRehabilitation

Identifiers

PMID39008228
PMCPMC11585512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.